In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
The FDA approved a new drug called Zepbound, which activates GLP-1 to help with obstructive sleep apnea, while also resulting ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...
It has FDA approval for weight loss, unlike Ozempic, which only has approval for type 2 diabetes. *Ozempic is not FDA-approved for weight loss. However, a doctor may prescribe it off-label for ...
Lawmakers are urging the FDA to address misleading advertisements by Hims & Hers, a telehealth company promoting injectable weight-loss drugs without adequate safety and risk disclosures.
an obesity medicine specialist and author of the new book “The Ozempic Revolution” shares the pros and cons of using GLP-1 medications for weight loss. The FDA has expanded the approval of Eli ...
There are three main types of injectable weight loss drugs approved by the Food and Drug Administration (FDA): semaglutide, liraglutide and tirzepatide. These are administered either daily or ...
Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials By Stephanie ... that these products are not FDA-approved." The commercial appears to be taking advantage of a perceived ...
Our FDA-approved label clearly warns that Mounjaro ... "I took semaglutide (Ozempic) short-term to kickstart weight loss," one commenter wrote. "I lost 80 pounds and have been off it for a year ...
We will focus on telehealth companies, like Jack & Jill, that offer Ozempic alternatives over the counter, such as compounded semaglutide and tirzepatide, as well as top FDA-approved weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results